Actuate Therapeutics Inc.
5 clinical trials · Sponsor
◉ Watch Actuate Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma (NCT04832438) | Actuate Therapeutics Inc. | 2030-12-18 |
| Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors (NCT07714395) | Actuate Therapeutics Inc. | 2026-10-01 |
| Actuate 1901: 9-ING-41 in Myelofibrosis (NCT04218071) | Actuate Therapeutics Inc. | 2020-08-20 |
| 9-ING-41 in Pediatric Patients With Refractory Malignancies. (NCT04239092) | Actuate Therapeutics Inc. | 2020-06-05 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
Track Actuate Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.